Dengvaxia tetravalent dengue vaccine regulatory update

Mexico’s Federal Commission for the Protection against Sanitary Risk (COFEPRIS) approved Dengvaxia from Sanofi’s Sanofi Pasteur vaccines division to prevent dengue fever infection in people ages 9-45 living in endemic areas. Sanofi said the approval is the first in the world for a dengue vaccine. Sanofi plans to launch the vaccine in Mexico in early 2016 but has not yet determined its price. ...